# Mice Model Market > Mice Model Market Size, Growth Research Report By Model Type & Service (Model Type, (Inbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Outbred Mice), Service, (Breeding, Cryopreservation, Rederivation, Quarantine and Other Services)), By Technology (CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies), By Therapeutic Area (Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases and Other Therapeutic Diseases), By Application (Drug Discovery & Development, Research Application and Personalized Medicine) – Competitor Industry Analysis and Trends Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.2% - **2024:** $ 1.68 Billion - **2025:** $ 1.78 Billion - **2035:** $ 3.25 Billion - **Key Players:** Charles River Laboratories (US), The Jackson Laboratory (US), Taconic Biosciences (US), Envigo (US), Harlan Laboratories (US), Crown Bioscience (US), Janvier Labs (FR), InVivo Biosystems (US), GenOway (FR) **Report ID:** MRFR/HC/20372-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/mice-model-market-21972 --- ## Market Summary ## **Mice Model Market Overview** As per MRFR analysis, the Mice Model Market Size was estimated at 1.68 (USD Billion) in 2024. The Mice Model Market Industry is expected to grow from 1.78 (USD Billion) in 2025 to 3.06 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.20% during the forecast period (2025 - 2034). The rising incidence of diseases worldwide, including chronic conditions, infectious diseases, cancer, neurological disorders and autoimmune diseases, is one of the key market drivers enhancing the market growth. Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Mice Model Market Trends** Market CAGR for the mice model is being driven by the rising incidence of diseases. As researchers seek to understand the underlying mechanisms of these diseases and develop effective treatments, mice models serve as indispensable tools in preclinical research. By mimicking human disease conditions, mice models enable researchers to study disease progression, test novel therapies, and evaluate treatment efficacy in a controlled environment. Additionally, the ability to create genetically modified mice with specific disease-relevant mutations allows researchers to gain valuable insights into disease mechanisms and potential therapeutic targets. As the demand for preclinical research models continues to grow in response to the rising burden of diseases, the use of mice models is expected to increase, further driving market growth. The growing focus on precision medicine, which emphasizes personalized treatment approaches based on individual genetic and molecular characteristics, is a significant driver of the Mice Model Market. Mice models play a crucial role in precision medicine research by providing researchers with tools to study disease heterogeneity, treatment responses, and genetic susceptibility factors. By utilizing genetically diverse mice models, researchers can mimic the genetic variability observed in human populations, allowing for a more accurate representation of disease phenotypes and treatment outcomes. Additionally, mice models enable the development and testing of targeted therapies tailored to specific genetic mutations or molecular pathways associated with diseases. As precision medicine continues to gain prominence in healthcare, the demand for mice models for preclinical research aimed at developing personalized therapeutic strategies is expected to increase, driving market growth. Drug development and safety assessment are key drivers of the Mice Model Market. Mice models play a crucial role in preclinical research for evaluating the safety and efficacy of new drug candidates before clinical trials. By utilizing mice models to study drug pharmacokinetics, pharmacodynamics, and toxicity profiles, researchers can identify potential adverse effects and optimize dosing regimens to enhance drug safety. Additionally, mice models allow for the investigation of drug interactions, metabolism, and distribution within the body, providing valuable insights into drug efficacy and potential side effects. With stringent regulatory requirements for drug approval, pharmaceutical companies rely on mice models to conduct comprehensive safety assessments and demonstrate the potential benefits of new therapies. As the demand for novel therapeutics continues to grow, the use of mice models in drug development and safety assessment is expected to drive market revenue growth. ## **Mice Model Market Segment Insights** ### **Mice Model Model Type & Service Insights** The Mice Model Market segmentation, based on Model Type & Service includes Model Type (Inbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Outbred Mice), Service (Breeding, Cryopreservation, Rederivation, Quarantine and Other services). In 2023, the Model Type segment dominated the market, accounting for 15% of market revenue due to several reasons. First, the diverse range of model types available, including inbred, outbred, transgenic, and knockout mice, caters to the specific research requirements of various industries and academic institutions. Second, the availability of comprehensive services, such as breeding, genotyping, phenotyping, and disease modeling, offers researchers convenience and flexibility in obtaining customized mice models tailored to their experimental needs. This combination of diverse model types and comprehensive services drives the dominance of this segment in the market. The Service Model Type & Service segment is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. First, increasing demand for customized mice models tailored to specific research needs drives the adoption of comprehensive services, including breeding, genotyping, and phenotyping. Second, outsourcing these services to specialized providers reduces operational costs and enhances research efficiency for pharmaceutical companies and academic institutions. Third, the growing trend towards outsourcing non-core activities further fuels the growth of this segment in the market. ### **Mice Model Technology Insights** The Mice Model Market segmentation, based on Technology, includes CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies. In 2023, the CRISPR/CAS9 category generated the most income due to its unparalleled precision, efficiency, and versatility in [genetic engineering](../../../reports/genetic-engineering-market-1528). This technology allows for the targeted modification of mouse genomes with unprecedented accuracy, enabling the creation of complex and precisely tailored mice models with specific genetic mutations relevant to human diseases. The widespread adoption of CRISPR/Cas9 technology by researchers and pharmaceutical companies underscores its dominance in driving innovation and advancements in mice model development. Microinjection technology is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to its established reliability and versatility in generating genetically modified mice. This technique allows for the precise introduction of DNA constructs into mouse embryos, enabling the creation of transgenic and knockout mice models with targeted genetic modifications. As researchers continue to demand customized and complex mice models for various research applications, microinjection technology remains a preferred method for genetic manipulation, driving its growth in the market. ### **Mice Model Therapeutic Area Insights** The Mice Model Market segmentation, based on Therapeutic Area, includes Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases and Other Therapeutic Diseases. In 2023, the Oncology category generated the most income due to several factors. First, the increasing incidence of cancer worldwide drives demand for preclinical research models to study tumor biology, drug efficacy, and treatment response. Second, mice models enable researchers to mimic human cancer conditions, facilitating the development and testing of novel oncology therapies. Third, ongoing advancements in genetic engineering technologies allow for the creation of sophisticated mice models that accurately recapitulate human cancer pathology, further fueling demand in this therapeutic area. The Metabolic Diseases Therapeutic Area is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. First, the rising prevalence of metabolic disorders such as diabetes, obesity, and metabolic syndrome drives the demand for preclinical models to study disease mechanisms and test potential therapies. Second, mice models allow researchers to investigate metabolic pathways, insulin resistance, and lipid metabolism, facilitating the development of novel treatments for metabolic diseases. This growing focus on metabolic disorders propels the demand for mice models in this therapeutic area, leading to the highest CAGR. ### **Mice Model Application Insights** The Mice Model Market segmentation, based on Application, includes Drug Discovery & Development, Research Application and Personalized Medicine. In 2023, the Drug Discovery & Development category generated the most income due to several key factors. First, mice models are indispensable tools in preclinical research for evaluating drug efficacy, safety, and pharmacokinetics. Second, their ability to accurately mimic human physiology and disease conditions enables researchers to screen potential drug candidates and assess their therapeutic potential before clinical trials. Third, ongoing advancements in genetic engineering technologies enhance the utility of mice models in drug discovery, solidifying their dominance in this application segment. The Research Application segment is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. First, increasing investment in basic and translational research across academic and research institutions drives the demand for mice models for studying fundamental biological processes, disease mechanisms, and therapeutic interventions. Second, the versatility of mice models allows researchers to investigate a wide range of research areas, including immunology, neuroscience, genetics, and toxicology, contributing to the segment's rapid growth. ### **Mice Model End User Insights** The Mice Model Market segmentation, based on End User, includes Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and CROS & CDMOS. In 2023, the Pharmaceutical & Biotechnology Companies category generated the most income (due to several pivotal factors. These companies heavily rely on mice models for preclinical drug development, safety assessment, and efficacy testing, driving consistent demand. Secondly, the increasing focus on developing novel therapeutics and precision medicine approaches further propels the adoption of mice models by pharmaceutical and biotechnology companies. Lastly, ongoing advancements in genetic engineering technologies enhance the utility of mice models in drug discovery and development, solidifying their dominance in this end-user segment. Academic & Research Institutes as an end user are experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several key factors. First, increasing investment in research and development activities across academic institutions and research centers drives the demand for mice models for basic and translational research. Second, collaborations between academia and industry foster innovation and drive the adoption of mice models in preclinical studies. Lastly, the growing focus on interdisciplinary research areas, including genetics, immunology, and neuroscience, further accelerates the demand for mice models among academic and research institutes, contributing to the segment's rapid growth. **Figure 1: Mice Model Market, by End User, 2023 & 2032 (USD Billion)** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Mice Model Regional Insights** By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. North America dominates the Mice Model Market for several reasons. Firstly, the region boasts a robust biomedical research ecosystem, with numerous academic institutions, pharmaceutical companies, and research organizations driving demand for mice models. Secondly, supportive government funding and regulatory frameworks encourage research and development activities in the region. Lastly, the presence of key market players and advanced infrastructure further strengthens North America's position as a leader in mice model research and development, contributing to its largest market share in the industry. Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. **Figure 2: ****Mice Model Market Share By Region 2023 (USD Billion)** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review Europe Mice Model market accounts for the second-largest market share due to a well-established biomedical research infrastructure. Europe holds the second-largest market share in the Mice Model Market due to several factors. Firstly, the region features a well-established biomedical research infrastructure, with prominent academic institutions and research organizations driving demand for mice models. Secondly, supportive government initiatives and funding bolster research and development activities in Europe. Thirdly, the presence of leading pharmaceutical and biotechnology companies further contributes to the region's significant market share in mice model research and development. Further, the German Mice Model market held the largest market share, and the UK Mice Model market was the fastest growing market in the European region. The Asia-Pacific Mice Model Market is expected to grow at the fastest CAGR from 2025 to 2034. The Asia Pacific region is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. Firstly, increasing investment in biomedical research and development across countries like China, Japan, and India drives demand for mice models. Secondly, rising pharmaceutical and biotechnology activities, coupled with a growing focus on personalized medicine, accelerate the adoption of mice models for preclinical research. Lastly, expanding collaborations between academia and industry further fuel market growth in the Asia Pacific region. Moreover, China’s Mice Model market held the largest market share, and the Indian Mice Model market was the fastest growing market in the Asia-Pacific region. ## **Mice Model Key Market Players & Competitive Insights** Leading players in the Mice Model Market are actively engaged in strategic initiatives to maintain their competitive edge. This includes expanding their product portfolios with innovative mice models, such as genetically engineered and humanized mice, to meet diverse market developments. Additionally, these players focus on enhancing their service offerings, including breeding, genotyping, and phenotyping services, to provide comprehensive solutions to researchers. Collaborations with academic institutions and pharmaceutical companies for research partnerships and licensing agreements also contribute to their competitive advantage. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Mice Model industry to benefit clients and increase the market sector. In recent years, the Mice Model industry has offered some of the most significant advantages to oncology. Major players in the Mice Model market, including Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others, are attempting to increase market demand by investing in research and development operations. Charles River Laboratories International, Inc. is a leading provider of mice models and related services in the Mice Model Market. With a global presence spanning North America, Europe, Asia Pacific, and other regions, Charles River offers a comprehensive portfolio of genetically engineered, immunodeficient, and humanized mice models tailored for preclinical research across various therapeutic areas. The company's extensive expertise in breeding, genotyping, and phenotyping services ensures the delivery of high-quality, reliable research models to pharmaceutical, biotechnology, academic, and government institutions worldwide. Through strategic collaborations, acquisitions, and investments in technology and innovation, Charles River Laboratories continues to strengthen its position as a trusted partner in advancing biomedical research and drug discovery efforts aimed at addressing unmet medical needs. Taconic Biosciences, Inc. is a prominent player in the Mice Model Market, offering a comprehensive range of genetically engineered mice models and related services. With a strong emphasis on innovation and quality, Taconic provides researchers worldwide with customized mice models tailored to specific research needs in various therapeutic areas. The company's extensive portfolio includes models for oncology, immunology, neurology, metabolic diseases, and more, facilitating preclinical research and drug discovery efforts. Taconic's commitment to customer satisfaction, along with its expertise in breeding, genotyping, and phenotyping services, ensures the delivery of reliable research models and support to pharmaceutical, biotechnology, and academic institutions globally. Through strategic partnerships and investments in research and development, Taconic Biosciences continues to drive advancements in the field of mice model research and preclinical studies. ### **Key Companies in the Mice Model market include** ## Mice Model Industry Developments - **Q1 2024: Mouse model offers new insights into sperm function, infertility** In January 2024, researchers at Cornell University announced the creation of a new mouse model to study sperm function and human infertility, overseen by Roy Cohen at the Baker Institute. The model is expected to advance understanding of infertility mechanisms. ## **Mice Model Market Segmentation** ### **Mice Model Model Type & Service Outlook** ### **Mice Model Technology Outlook** ### **Mice Model Therapeutic Area Outlook** ### **Mice Model Application Outlook** ### **Mice Model End User Outlook** ### **Mice Model Regional Outlook** **North America** **Europe** **Asia-Pacific** **Rest of the World** ## Market Drivers ### Rising Demand for Drug Discovery The Mice Model Market is experiencing a notable increase in demand for drug discovery processes. As pharmaceutical companies strive to develop new therapeutics, the reliance on mice models for preclinical testing has intensified. In 2025, the market for drug discovery is projected to reach approximately 50 billion USD, with a significant portion attributed to the utilization of mice models. These models provide critical insights into pharmacokinetics and pharmacodynamics, thereby enhancing the efficiency of drug development. Furthermore, the ability to simulate human diseases in mice allows researchers to identify potential drug candidates more effectively. This trend indicates a robust growth trajectory for the Mice Model Market, as the need for innovative therapies continues to rise. ### Increased Focus on Cancer Research The Mice Model Market is significantly influenced by the heightened focus on cancer research. With cancer remaining one of the leading causes of mortality, researchers are increasingly utilizing mice models to study tumor biology and test novel treatment strategies. In 2025, it is estimated that cancer research will account for over 30% of the total research funding allocated to preclinical studies. Mice models enable scientists to investigate the efficacy of new drugs and therapies in a controlled environment, thereby accelerating the pace of discovery. This growing emphasis on cancer research is likely to drive demand for specialized mice models, further propelling the Mice Model Market forward. ### Regulatory Support for Animal Research The Mice Model Market is positively impacted by regulatory support for animal research. Regulatory bodies are increasingly acknowledging the necessity of animal models in the drug development process, which has led to streamlined approval processes for studies involving mice. In 2025, it is anticipated that regulatory frameworks will continue to evolve, providing clearer guidelines for researchers. This supportive environment encourages investment and innovation within the Mice Model Market, as companies and institutions feel more confident in pursuing studies that utilize these models. The alignment of regulatory policies with scientific needs is likely to foster a more robust market for mice models in the coming years. ### Growing Investment in Biomedical Research The Mice Model Market is experiencing a surge in investment directed towards biomedical research. Governments and private entities are recognizing the importance of animal models in understanding complex biological processes and developing new therapies. In 2025, funding for biomedical research is projected to exceed 100 billion USD, with a considerable portion allocated to studies involving mice models. This influx of capital is likely to enhance research capabilities and foster innovation within the Mice Model Market. As more resources become available, researchers can explore novel applications and refine existing models, ultimately contributing to the advancement of medical science. ### Technological Advancements in Mice Models The Mice Model Market is benefiting from rapid technological advancements that enhance the capabilities of these models. Innovations such as CRISPR gene editing and advanced imaging techniques are revolutionizing the way researchers utilize mice in their studies. In 2025, the market for genetically modified mice is expected to grow by approximately 20%, reflecting the increasing adoption of these technologies. These advancements allow for more precise modeling of human diseases, leading to improved translational research outcomes. As researchers seek to leverage these technologies for better experimental results, the Mice Model Market is poised for substantial growth, driven by the demand for more sophisticated and reliable models. ## Future Outlook The Mice Model Market is projected to grow at a 6.2% CAGR from 2025 to 2035, driven by advancements in genetic engineering, increasing demand for personalized medicine, and rising investments in research. **New opportunities:** - Development of genetically modified mouse models for specific diseases. Expansion of contract research organizations offering Mice model services. Integration of AI technologies for enhanced data analysis in research. By 2035, the Mice Model Market is expected to be robust, driven by innovation and strategic partnerships. ## Segment Insights ### By Model Type: Genetically Engineered Mice (Largest) vs. Inbred Mice (Fastest-Growing) The Mice Model Market exhibits a diverse landscape characterized by varying market share distributions among different model types. Genetically Engineered Mice currently hold a significant portion of the market share, driven by their high demand in genetic studies and pharmaceutical research. In contrast, Inbred Mice are gaining momentum and are projected to capture more market share as researchers increasingly rely on their consistent genetic background for experimental reproducibility. Growth trends in the Mice Model Market indicate a shift towards more specialized models, with Genetically Engineered Mice remaining a staple due to their unique traits. However, the emerging trend of Inbred Mice is attributed to their ease of handling and standardized genetic profiles, making them attractive for various research applications involving genetic modifications and behavior studies. The overall growth is further fueled by advancements in genetic engineering technologies that enhance the capabilities of these models. Genetically Engineered Mice (Dominant) vs. Inbred Mice (Emerging) Genetically Engineered Mice are at the forefront of the Mice Model Market, recognized for their critical role in advancing biomedical research, particularly in human disease modeling and drug development. These models are created through targeted genetic modifications, providing researchers with a powerful tool for dissecting disease mechanisms and identifying potential therapeutic targets. Their dominance in the market stems from their versatility and applicability across a range of research fields. On the other hand, Inbred Mice serve as an emerging model, characterized by genetically uniform strains that allow for high reproducibility in experiments. This consistency makes them particularly valuable in studies requiring genetic stability, enhancing the reliability of experimental outcomes. Research institutions are increasingly adopting Inbred Mice for specific applications where genetic variations might confound results, thereby driving their growing market relevance. ### By Service: Breeding (Largest) vs. Cryopreservation (Fastest-Growing) In the Mice Model Market, the service segment showcases a diverse array of offerings, with breeding taking a significant share as the largest component. The distribution indicates that breeding remains essential for developing genetically engineered models, which continues to drive its prevalence among research institutions. Following this, cryopreservation has emerged as a crucial service, allowing for the long-term storage of genetic material, thereby increasing its market presence and importance as research practices evolve. The growth trends within this segment highlight an increasing reliance on cryopreservation and rederivation services. Factors such as advancements in genetic technologies and a growing demand for customized mouse models are propelling the expansion of these services. Additionally, the need for maintaining genetic integrity during long-term storage is raising awareness around quarantine solutions, thus further stimulating this segment's development and adaptability in the face of emerging research needs. Breeding (Dominant) vs. Quarantine (Emerging) Breeding services in the Mice Model Market are crucial for ensuring the availability of genetically specific strains for experimentation. This dominant service allows researchers to develop customized models tailored for specific studies, fundamentally supporting various biomedical research fields. On the other hand, the quarantine service has emerged due to growing regulatory demands and the necessity for biosecurity. Though not as established as breeding, quarantine plays an essential role in safeguarding genetic stocks from contamination and ensuring the health of colonies. This emerging service is increasingly recognized as integral for compliance and maintaining quality standards in research institutions, highlighting its importance in a rapidly evolving market landscape. ### By Technology: CRISPR/CAS9 (Largest) vs. Microinjection (Fastest-Growing) The Mice Model Market showcases a diverse range of technologies, with [CRISPR/CAS9 technology](https://www.marketresearchfuture.com/reports/crispr-technology-market-9251) holding the largest market share. This cutting-edge gene-editing tool has transformed research by allowing precise modifications to the mice genome. Microinjection follows as a rapidly growing segment, favored for its direct method of introducing genetic material into the embryos. Other technologies, such as embryonic stem cell injection and nuclear transfer, also contribute to the market but have seen slower growth relative to these two dominant technologies. Overall, the competition among these technologies illustrates significant advancements in genetic research and experimentation. As the market continues to evolve, several trends indicate robust growth, particularly for microinjection techniques due to their cost-effectiveness and adaptability in various applications. Researchers increasingly prioritize swift and efficient methodologies, driving the adoption of microinjection as labs seek to enhance genetic engineering capabilities. Furthermore, advancements in CRISPR/CAS9 are paving the way for new solutions in therapeutic applications, stimulating market interest and investment. The integration of automation and AI in these technologies presents additional growth avenues, indicating a promising future for the mice model market. Technology: CRISPR/CAS9 (Dominant) vs. Microinjection (Emerging) CRISPR/CAS9 technology stands out in the Mice Model Market for its precision and versatility, making it the dominant force in gene editing. Researchers favor its ability to easily create knock-out and knock-in models, which are pivotal in studying genetic diseases and potential therapies. On the other hand, Microinjection is emerging as an advantageous technique, especially in labs focusing on reproductive biology and the development of transgenic mice. This method offers a direct approach for gene transfer, allowing for high efficiency in model generation. While CRISPR/CAS9 is widely recognized for its groundbreaking contributions to genetic engineering, Microinjection is rapidly establishing its worth by enhancing the accessibility and performance of transgenic technologies. ### By Therapeutic Area: Oncology (Largest) vs. Immunology (Fastest-Growing) In the Mice Model Market, the therapeutic area of Oncology holds the largest share, reflecting its pivotal role in advancing cancer research through innovative model systems. This segment significantly drives the demand for specialized mice models that mimic tumor development and progression, essential for testing new therapies and drug candidates. In contrast, the Immunology segment, while smaller, is emerging rapidly, driven by the increasing prevalence of autoimmune diseases and the growth in immunotherapy research. Researchers are increasingly relying on mice models to explore disease mechanisms and develop novel treatments, adding to the segment’s allure. Oncology: Dominant vs. Immunology: Emerging Oncology remains the dominant therapeutic area in the Mice Model Market, benefiting from extensive funding and research initiatives aimed at tackling various forms of cancer. The availability of tailor-made models that replicate specific tumor types enhances their value in preclinical settings. Meanwhile, the Immunology segment is gaining traction, attributed to advancements in understanding the immune system and the rising focus on immunotherapies, such as monoclonal antibodies and CAR-T cell therapies. Both segments are characterized by their reliance on sophisticated genetic modifications in mice models, driving innovation to meet the specialized needs of researchers in their respective fields. ### By Application: Drug Discovery & Development (Largest) vs. Personalized Medicine (Fastest-Growing) In the Mice Model Market, the application segment is primarily dominated by Drug Discovery & Development, which holds the largest market share. This segment encompasses various applications of mice models, specifically focused on understanding disease mechanisms and testing potential therapeutic targets. Research Applications follow closely, driven by advancements in genetic engineering and the need for innovative therapies. Personalized Medicine, while currently a smaller share, is quickly gaining traction due to the rising prevalence of genetic-based treatments and targeted therapies that demand customized applications of mice models. Drug Discovery & Development (Dominant) vs. Personalized Medicine (Emerging) Drug Discovery & Development remains the dominant force in the Mice Model Market, characterized by high investment levels and a robust pipeline of new drug candidates. This segment benefits from collaborations with pharmaceutical companies, academic institutions, and biotechnology firms, leveraging synergies for faster innovation. Meanwhile, Personalized Medicine is emerging as a pivotal area, driven by the seismic shift towards patient-specific therapies. This trend requires models that can accurately reflect individual genetic profiles and disease states, thus ensuring tailored therapeutic approaches. As the market adapts to these evolving needs, both segments will play critical roles, with Drug Discovery maintaining its leadership while Personalized Medicine secures its position as a key growth driver. ### By End User: Pharmaceutical & Biotechnology Companies (Largest) vs. Academic & Research Institutes (Fastest-Growing) In the Mice Model Market, the end user segment is primarily characterized by three key players: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and CROS & CDMOS. Among these, Pharmaceutical & Biotechnology Companies hold the largest market share due to their extensive research and development activities requiring cost-effective and reliable animal models. Academic & Research Institutes follow, leveraging mice models for various scientific studies, while CROS & CDMOS are increasingly utilizing these models to support their clinical trial and drug development processes. Looking at growth trends, Academic & Research Institutes are currently the fastest-growing segment within the Mice Model Market. This growth can be attributed to rising government funding for research, an increased focus on personalized medicine, and a growing trend toward collaborative research initiatives. Pharmaceutical & Biotechnology Companies, while still dominant, are also seeing a shift as they expand their contract research partnerships with CROS, further fueling the demand for mice model services in drug discovery and development activities. Pharmaceutical & Biotechnology Companies (Dominant) vs. CROS & CDMOS (Emerging) The Pharmaceutical & Biotechnology Companies segment is characterized by its substantial investment in R&D and a continuous need for innovative drug development solutions, making it the dominant player in the mice model market. These companies rely heavily on mice models for preclinical studies and toxicology assessments, offering a competitive edge in the drug development process. On the other hand, CROS & CDMOS are emerging as vital contributors to this market due to their role in providing essential services for outsourcing pharmacological studies and trials. Their flexible operational capabilities and ability to access a variety of mice models position them as indispensable partners for pharmaceutical companies, fostering faster timelines and efficiency in navigating regulatory requirements. ## Regional Market Share Analysis ### North America : Leading Innovation and Research North America is the largest market for mice models, accounting for approximately 45% of the global share. The region's growth is driven by robust research and development activities, increasing investments in biotechnology, and a strong regulatory framework that supports animal research. The demand for genetically modified mice models is on the rise, fueled by advancements in personalized medicine and drug development. The United States is the leading country in this market, hosting major players such as Charles River Laboratories and The Jackson Laboratory. The competitive landscape is characterized by a mix of established firms and emerging biotech companies. Canada also plays a significant role, contributing to the market with its growing research initiatives and collaborations in the life sciences sector. ### Europe : Emerging Regulatory Frameworks Europe is the second-largest market for mice models, holding around 30% of the global share. The region's growth is propelled by increasing funding for research projects, particularly in the fields of genetics and pharmacology. Regulatory bodies are establishing frameworks that promote ethical research practices, which further catalyzes market growth. The demand for innovative models is rising, especially in response to the growing focus on personalized medicine and disease modeling. Leading countries in this region include Germany, France, and the UK, which are home to several key players like Janvier Labs and GenOway. The competitive landscape is marked by collaborations between academic institutions and industry players, enhancing research capabilities. The presence of strong regulatory bodies ensures compliance and fosters innovation in the mice model market. ### Asia-Pacific : Rapidly Growing Research Sector Asia-Pacific is witnessing rapid growth in the mice model market, accounting for approximately 20% of the global share. The region's expansion is driven by increasing investments in biotechnology and pharmaceutical research, coupled with a growing number of research institutions. Countries like China and India are leading this growth, supported by favorable government policies and funding initiatives aimed at enhancing research capabilities and infrastructure. China is the largest market in the region, with significant contributions from local companies and collaborations with international firms. The competitive landscape is evolving, with a mix of established players and new entrants. The demand for advanced mice models is increasing, particularly in the fields of cancer research and drug development, positioning Asia-Pacific as a key player in the global market. ### Middle East and Africa : Emerging Research Opportunities The Middle East and Africa (MEA) region is gradually emerging in the mice model market, holding about 5% of the global share. The growth is primarily driven by increasing investments in healthcare and research initiatives, particularly in countries like South Africa and the UAE. The region is witnessing a rise in biotechnology firms and academic collaborations, which are essential for advancing research capabilities and infrastructure. South Africa is leading the market in the MEA region, with a growing number of research institutions focusing on genetic studies and drug development. The competitive landscape is characterized by a mix of local and international players, with increasing interest from global firms looking to expand their presence. The region's potential for growth is significant, as more funding and resources are allocated to research and development. ## Competitive Benchmarking The Mice Model Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for advanced research models in drug discovery, genetic research, and personalized medicine. Key players such as Charles River Laboratories (US), The Jackson Laboratory (US), and Envigo (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Charles River Laboratories (US) focuses on innovation through the development of genetically engineered models, while The Jackson Laboratory (US) emphasizes its extensive repository of mouse models to support precision medicine initiatives. Envigo (US), on the other hand, is enhancing its operational capabilities through strategic partnerships aimed at expanding its service offerings in the preclinical space. Collectively, these strategies contribute to a competitive environment that is increasingly centered on innovation and specialized services. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The Mice Model Market appears moderately fragmented, with a mix of established players and emerging companies vying for market share. The collective influence of these key players shapes the market structure, as they leverage their unique strengths to capture diverse segments of the market. In August Charles River Laboratories (US) announced a strategic partnership with a leading biotechnology firm to co-develop novel mouse models for immuno-oncology research. This collaboration is poised to enhance Charles River's portfolio, allowing it to offer cutting-edge models that meet the evolving needs of researchers in the oncology field. Such partnerships not only bolster product offerings but also position the company as a leader in a niche market segment. In July The Jackson Laboratory (US) launched a new initiative aimed at expanding its genetic mouse model offerings, specifically targeting rare genetic disorders. This initiative underscores the laboratory's commitment to advancing genetic research and aligns with the growing trend towards personalized medicine. By focusing on rare diseases, The Jackson Laboratory (US) is likely to attract a specialized clientele, thereby enhancing its competitive edge. In September Envigo (US) unveiled a new facility dedicated to the production of high-quality mouse models, emphasizing its commitment to sustainability and ethical practices in animal research. This facility is expected to streamline operations and improve supply chain reliability, which is increasingly critical in the current market landscape. Envigo's focus on sustainability may resonate well with clients who prioritize ethical considerations in their research practices. As of October the Mice Model Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in research methodologies. Strategic alliances are becoming increasingly pivotal, as companies seek to enhance their capabilities and broaden their service offerings. Looking ahead, competitive differentiation is likely to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition suggests that companies that prioritize these aspects will be better positioned to thrive in the evolving landscape. ## Recent News & Developments - **Q1 2024: Mouse model offers new insights into sperm function, infertility** In January 2024, researchers at Cornell University announced the creation of a new mouse model to study sperm function and human infertility, overseen by Roy Cohen at the Baker Institute. The model is expected to advance understanding of infertility mechanisms. ## Report Scope | MARKET SIZE 2024 | 1.677(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 1.781(USD Billion) | | MARKET SIZE 2035 | 3.251(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.2% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Charles River Laboratories (US), The Jackson Laboratory (US), Taconic Biosciences (US), Envigo (US), Harlan Laboratories (US), Crown Bioscience (US), Janvier Labs (FR), InVivo Biosystems (US), GenOway (FR) | | Segments Covered | Model Type & Service, Technology, Therapeutic Area, Application | | Key Market Opportunities | Advancements in genetic engineering enhance precision and efficacy in the Mice Model Market. | | Key Market Dynamics | Rising demand for genetically engineered mice models drives innovation and competition among biotechnology firms. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Mice Model Market as of 2024?** A: The Mice Model Market was valued at 1.677 USD Billion in 2024. **Q: What is the projected market valuation for the Mice Model Market in 2035?** A: The market is projected to reach 3.251 USD Billion by 2035. **Q: What is the expected CAGR for the Mice Model Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Mice Model Market during the forecast period 2025 - 2035 is 6.2%. **Q: Which companies are considered key players in the Mice Model Market?** A: Key players in the Mice Model Market include Charles River Laboratories, The Jackson Laboratory, and Taconic Biosciences. **Q: What segment of the Mice Model Market had the highest valuation in 2024?** A: In 2024, the Drug Discovery & Development segment had the highest valuation at 0.8 USD Billion. **Q: How much is the Inbred Mice segment projected to grow by 2035?** A: The Inbred Mice segment is projected to grow from 0.335 USD Billion in 2024 to 0.65 USD Billion by 2035. **Q: What is the valuation range for the Cryopreservation service in the Mice Model Market?** A: The Cryopreservation service is valued between 0.3 USD Billion and 0.6 USD Billion. **Q: Which therapeutic area is expected to see significant growth in the Mice Model Market?** A: The Oncology therapeutic area is expected to grow significantly, with a valuation range of 0.5 USD Billion to 0.95 USD Billion. **Q: What is the projected valuation for the Academic & Research Institutes segment by 2035?** A: The Academic & Research Institutes segment is projected to reach between 0.5 USD Billion and 0.9 USD Billion by 2035. **Q: What technologies are driving advancements in the Mice Model Market?** A: Technologies such as CRISPR/CAS9 and Microinjection are driving advancements, with valuations ranging from 0.4 USD Billion to 0.95 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/mice-model-market-21972*